<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97253">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01650857</url>
  </required_header>
  <id_info>
    <org_study_id>HannoverMS PH-Reha001</org_study_id>
    <nct_id>NCT01650857</nct_id>
  </id_info>
  <brief_title>Pulmonary Hypertension: Efficacy of a 3 Week Inpatient Rehabilitation on Physical Condition, Body Composition and Health Related Quality of Life</brief_title>
  <official_title>Pulmonary Hypertension: Efficacy of a 3 Week Inpatient Pulmonary Rehabilitation on Physical Condition, Body Composition and Health Related Quality of Life - an Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Klinik Bad Fallingbostel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hannover Medical School</source>
  <oversight_info>
    <authority>Germany: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary hypertension (PH) leads to impaired physical condition (PC), body composition (BC)
      and health-related quality of life (HRQOL). We hypothesized that a 3 week inpatient
      pulmonary rehabilitation (PR) improves PC, BC and HRQOL.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulmonary hypertension (PH) impairs physical condition (PC), body composition (BC) and
      health-related quality of life (HRQOL).

      Specific pharmacological treatment and - in selected patients, refractory to agents - lung
      or combined heart and lung transplantation can improve physical functioning and long term
      survival. Initial trials with limited numbers of patients were encouraging. Investigation of
      larger cohorts is essential to assess the efficacy of rehabilitation programmes in PH.

      We hypothesize that a 3 week inpatient pulmonary rehabilitation (PR) improves PC, BC and
      HRQOL in patients with PH in functional classes (FC) II and III. Critical ill patients with
      a functional class IV are excluded. All patients with PH undergo a 3-week inpatient
      rehabilitation program (interval bicycle and strength training, physiotherapy, psychological
      support, education). Exercise testing (peak work load (PWL) 6-min-walk distance), body
      composition (bioimpedance analysis BIA: lean body mass (LBM), body cell mass (BCM), BCM/LBM
      ratio, phase angle (PA)) and HRQOL (SF 36 questionnaire) are assessed at baseline and
      completion of PR.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">September 2012</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Exercise capacity</measure>
    <time_frame>3 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Exercise capacity (peak work load and 6-minute walk distance at completion of an 3-week inpatient pulmonary rehabilitation)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>3 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Body composition (bioimpedance analysis)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Health related Quality of Life</measure>
    <time_frame>3 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Health related Quality of Life (Short form 36 questionnaire)</description>
  </other_outcome>
  <other_outcome>
    <measure>Right ventricular function</measure>
    <time_frame>3 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Right ventricular function (echocardiography: estimated right ventricular systolic pressure, Tricuspid annular plane systolic  excursion, left ventricular eccentricity index)</description>
  </other_outcome>
  <other_outcome>
    <measure>Activities of daily living</measure>
    <time_frame>3 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Activities of daily living  (Barthel`s Index)</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pulmonary Hypertension: Efficacy of Rehabilitation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with pulmonary hypertension in World Heart Organization functional classification
        classes (FC) II and III
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of pulmonary hypertension

          -  Functional class II-III

        Exclusion Criteria:

          -  Functional class I and IV

          -  Right heart decompensation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin G Dierich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Respiratory Diseases, Hannover Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin G Dierich, MD</last_name>
    <phone>+49 532 3530</phone>
    <email>dierich.martin@mh-hannover.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Fuehner, MD</last_name>
    <phone>+ 49 532 3530</phone>
    <email>fuehner.thomas@mh-hannover.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinik Bad Fallingbostel</name>
      <address>
        <city>Bad Fallingbostel</city>
        <state>Lower Saxony</state>
        <zip>29683</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin G Dierich, MD</last_name>
      <phone>+49 5162 44 754</phone>
      <email>dierich@klinik-fallingbostel.de</email>
    </contact>
    <investigator>
      <last_name>Martin G Dierich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Rosenkranz S, Ghofrani HA, Grünig E, Hoeper MM. Cologne Consensus Conference on pulmonary hypertension. Int J Cardiol. 2011 Dec;154 Suppl 1:S1-2. doi: 10.1016/S0167-5273(11)70487-9.</citation>
    <PMID>22221968</PMID>
  </reference>
  <reference>
    <citation>Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT), Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009 Dec;34(6):1219-63. Epub 2009 Sep 12.</citation>
    <PMID>19749199</PMID>
  </reference>
  <reference>
    <citation>Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, Meyer FJ, Karger G, Buss J, Juenger J, Holzapfel N, Opitz C, Winkler J, Herth FF, Wilkens H, Katus HA, Olschewski H, Grunig E. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006 Oct 3;114(14):1482-9. Epub 2006 Sep 18.</citation>
    <PMID>16982941</PMID>
  </reference>
  <verification_date>July 2012</verification_date>
  <lastchanged_date>July 31, 2012</lastchanged_date>
  <firstreceived_date>July 21, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hannover Medical School</investigator_affiliation>
    <investigator_full_name>Martin G Dierich, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Pulmonary hypertension</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Exercise capacity</keyword>
  <keyword>Body composition</keyword>
  <keyword>Health related Quality of Life</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
